Publications by authors named "H Voet"

Claim this Profile
I
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Alison C Tree, Victoria Hinder, Andrew Chan, Shaun Tolan, Peter Ostler, Hans van der Voet

Lancet Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncertainties in the Extrapolation of In Vitro Data in Human Risk Assessment: A Case Study of qIVIVE for Imazalil Using the Monte Carlo Risk Assessment Platform.
Anne Zwartsen, Marco Zeilmaker, Waldo J de Boer, Emiel Rorije, Hilko van der Voet

Chem Res Toxicol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial.
Nicholas van As, Binnaz Yasar, Clare Griffin, Jaymini Patel, Alison C Tree, Hans van der Voet

Eur Urol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growing at the arid edge: Anatomical variations in leaves are more extensive than in stems of five Mediterranean species across contrasting moisture regimes.
Asaf Alon, Neta Ginzburg, Hanita Zemach, Hillary Voet, Shabtai Cohen

Am J Bot· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.
Nicholas van As, Clare Griffin, Alison Tree, Jaymini Patel, Peter Ostler, Hans van der Voet

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis